Caveolin-1 increases proinflammatory chemoattractants and blood–retinal barrier breakdown but decreases leukocyte recruitment in inflammation

Investigative Ophthalmology and Visual Science

Volumn 55, Issue 10, 2014, Pages 6224-6234

  Li, Xiaoman ^a,b   Gu, Xiaowu ^a   Boyce, Timothy M ^a   Zheng, Min ^a   Reagan, Alaina M ^a   Qi, Hui ^a   Mandal, Nawajes ^a   Cohen, Alex W ^a   Callegan, Michelle C ^a   Carr, Daniel J J ^a   Elliott, Michael H ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Blood retinal barrier; Caveolin; Cytokines; Inflammation

Indexed keywords

CAVEOLIN 1; CD45 ANTIGEN; CHEMOATTRACTANT; CLAUDIN 5; CXCL1 CHEMOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; OCCLUDIN; PROTEIN ZO1; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; CAV1 PROTEIN, MOUSE; CHEMOTACTIC FACTOR; RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASSAY; BLOOD RETINA BARRIER; CONTROLLED STUDY; FITC DEXTRAN PERMEABILITY ASSAY; FLOW CYTOMETRY; GENOTYPE; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFLAMMATION; INNATE IMMUNITY; LEUKOCYTE; LEUKOSTASIS; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; UVEITIS; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ANIMALS; BLOOD-RETINAL BARRIER; BLOTTING, WESTERN; CAVEOLIN 1; CHEMOTACTIC FACTORS; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; IMMUNITY, INNATE; IMMUNOHISTOCHEMISTRY; LEUKOCYTES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; REAL-TIME POLYMERASE CHAIN REACTION; RNA; UVEITIS;

EID: 84908099168     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.14-14613     Document Type: Article

References (75)

1. Streilein JW. Ocular immune privilege: the eye takes a dim but practical view of immunity and inflammation. J Leukoc Biol. 2003;74:179–185
2. Caspi RR. A look at autoimmunity and inflammation in the eye. J Clin Invest. 2010;120:3073–3083
3. Strauss O. The retinal pigment epithelium in visual function. Physiol Rev. 2005;85:845–881
4. Klaassen I, Van Noorden CJ, Schlingemann RO. Molecular basis of the inner blood-retinal barrier and its breakdown in diabetic macular edema and other pathological conditions. Prog Retin Eye Res. 2013;34:19–48
5. Streilein JW, Ma N, Wenkel H, Ng TF, Zamiri P. Immunobiology and privilege of neuronal retina and pigment epithelium transplants. Vision Res. 2002;42:487–495
6. Wenkel H, Streilein JW. Evidence that retinal pigment epithelium functions as an immune-privileged tissue. Invest Ophthalmol Vis Sci. 2000;41:3467–3473
7. Sugita S, Horie S, Yamada Y, Mochizuki M. Inhibition of B-cell activation by retinal pigment epithelium. Invest Ophthalmol Vis Sci. 2010;51:5783–5788
8. Forrester JV. Bowman lecture on the role of inflammation in degenerative disease of the eye. Eye (Lond). 2013;27:340–352
9. Nickells RW, Howell GR, Soto I, John SW. Under pressure: cellular and molecular responses during glaucoma, a common neurodegeneration with axonopathy. Annu Rev Neurosci. 2012;35:153–179
10. Kleinman ME, Baffi JZ, Ambati J. The multifactorial nature of retinal vascular disease. Ophthalmologica. 2010;224(suppl 1): 16–24
11. Antonetti DA, Klein R, Gardner TW. Diabetic retinopathy. N Engl J Med. 2012;366:1227–1239
12. Parton RG, del Pozo MA. Caveolae as plasma membrane sensors, protectors and organizers. Nat Rev Mol Cell Biol. 2013;14:98–112
13. Cohen AW, Hnasko R, Schubert W, Lisanti MP. Role of caveolae and caveolins in health and disease. Physiol Rev. 2004;84: 1341–1379
14. Gu X, Reagan A, Yen A, Bhatti F, Cohen AW, Elliott MH. Spatial and temporal localization of caveolin-1 protein in the developing retina. Adv Exp Med Biol. 2014;801:15–21
15. Roesch K, Jadhav AP, Trimarchi JM, et al. The transcriptome of retinal M¨uller glial cells. J Comp Neurol. 2008;509:225–238
16. Nelson BR, Ueki Y, Reardon S, et al. Genome-wide analysis of M¨uller glial differentiation reveals a requirement for Notch signaling in postmitotic cells to maintain the glial fate. PLoS One. 2011;6:e22817
17. Mora RC, Bonilha VL, Shin BC, et al. Bipolar assembly of caveolae in retinal pigment epithelium. Am J Physiol Cell Physiol. 2006;290:C832–C843
18. Bridges CC, El-Sherbeny A, Roon P, et al. A comparison of caveolae and caveolin-1 to folate receptor alpha in retina and retinal pigment epithelium. Histochem J. 2001;33:149–158
19. Klaassen I, Hughes JM, Vogels IM, Schalkwijk CG, Van Noorden CJ, Schlingemann RO. Altered expression of genes related to blood-retina barrier disruption in streptozotocininduced diabetes. Exp Eye Res. 2009;89:4–15
20. Stitt AW, Burke GA, Chen F, McMullen CB, Vlassara H. Advanced glycation end-product receptor interactions on microvascular cells occur within caveolin-rich membrane domains. FASEB J. 2000;14:2390–2392
21. Feng Y, Venema VJ, Venema RC, Tsai N, Behzadian MA, Caldwell RB. VEGF-induced permeability increase is mediated by caveolae. Invest Ophthalmol Vis Sci. 1999;40:157–167
22. Hofman P, Blaauwgeers HG, Tolentino MJ, et al. VEGF-A induced hyperpermeability of blood-retinal barrier endothelium in vivo is predominantly associated with pinocytotic vesicular transport and not with formation of fenestrations. Vascular endothelial growth factor-A. Curr Eye Res. 2000;21: 637–645
23. Gu X, Fliesler SJ, Zhao YY, Stallcup WB, Cohen AW, Elliott MH. Loss of caveolin-1 causes blood-retinal barrier breakdown, venous enlargement, and mural cell alteration. Am J Pathol. 2014;184:541–555
24. Caldwell RB, Slapnick SM. Freeze-fracture and lanthanum studies of the retinal microvasculature in diabetic rats. Invest Ophthalmol Vis Sci. 1992;33:1610–1619
25. Raviola G, Butler JM. Unidirectional vesicular transport mechanism in retinal vessels. Invest Ophthalmol Vis Sci. 1983;24:1465–1474
26. Gardiner TA, Archer DB. Does unidirectional vesicular transport occur in retinal vessels? Br J Ophthalmol. 1986; 70:249–254
27. Elliott MH, Nash ZA, Takemori N, Fliesler SJ, McClellan ME, Naash MI. Differential distribution of proteins and lipids in detergent-resistant and detergent-soluble domains in rod outer segment plasma membranes and disks. J Neurochem. 2008; 104:336–352
28. Kachi S, Yamazaki A, Usukura J. Localization of caveolin-1 in photoreceptor synaptic ribbons. Invest Ophthalmol Vis Sci. 2001;42:850–852
29. Boesze-Battaglia K, Dispoto J, Kahoe MA. Association of a photoreceptor-specific tetraspanin protein, ROM-1, with triton X-100-resistant membrane rafts from rod outer segment disk membranes. J Biol Chem. 2002;277:41843–41849
30. Elliott MH, Fliesler SJ, Ghalayini AJ. Cholesterol-dependent association of caveolin-1 with the transducin alpha subunit inbovine photoreceptor rod outer segments: disruption by cyclodextrin and guanosine 50-O-(3-thiotriphosphate). Biochemistry. 2003;42:7892–7903
31. Berta AI, Boesze-Battaglia K, Magyar A, Szel A, Kiss AL. Localization of caveolin-1 and c-src in mature and differentiating photoreceptors: raft proteins co-distribute with rhodopsin during development. J Mol Histol. 2011;42:523–533
32. Chen W, Jump DB, Esselman WJ, Busik JV. Inhibition of cytokine signaling in human retinal endothelial cells through modification of caveolae/lipid rafts by docosahexaenoic acid. Invest Ophthalmol Vis Sci. 2007;48:18–26
33. Opreanu M, Tikhonenko M, Bozack S, et al. The unconventional role of acid sphingomyelinase in regulation of retinal microangiopathy in diabetic human and animal models. Diabetes. 2011;60:2370–2378
34. Li X, McClellan ME, Tanito M, et al. Loss of caveolin-1 impairs retinal function due to disturbance of subretinal microenvironment. J Biol Chem. 2012;287:16424–16434
35. Hauck SM, Dietter J, Kramer RL, et al. Deciphering membraneassociated molecular processes in target tissue of autoimmune uveitis by label-free quantitative mass spectrometry. Mol Cell Proteomics. 2010;9:2292–2305
36. Jin Y, Lee SJ, Minshall RD, Choi AM. Caveolin-1: a critical regulator of lung injury. Am J Physiol Lung Cell Mol Physiol. 2011;300:L151–L160
37. Chidlow JH Jr, Sessa WC. Caveolae, caveolins, and cavins: complex control of cellular signalling and inflammation. Cardiovasc Res. 2010;86:219–225
38. Mirza MK, Yuan J, Gao XP, et al. Caveolin-1 deficiency dampens Toll-like receptor 4 signaling through eNOS activation. Am J Pathol. 2010;176:2344–2351
39. Walton KA, Cole AL, Yeh M, et al. Specific phospholipid oxidation products inhibit ligand activation of toll-like receptors 4 and 2. Arterioscler Thromb Vasc Biol. 2003;23: 1197–1203
40. Tsai TH, Chen SF, Huang TY, et al. Impaired Cd14 and Cd36 expression, bacterial clearance, and Toll-like receptor 4-Myd88 signaling in caveolin-1-deleted macrophages and mice. Shock. 2011;35:92–99
41. Jiao H, Zhang Y, Yan Z, et al. Caveolin-1 Tyr14 phosphorylation induces interaction with TLR4 in endothelial cells and mediates MyD88-dependent signaling and sepsis-induced lung inflammation. J Immunol. 2013;191:6191–6199
42. Medina FA, Cohen AW, de Almeida CJ, et al. Immune dysfunction in caveolin-1 null mice following infection with Trypanosoma cruzi (Tulahuen strain). Microbes Infect. 2007;9: 325–333
43. Reidy T, Rittenberg A, Dwyer M, D’Ortona S, Pier G, Gadjeva M. Homotrimeric macrophage migration inhibitory factor (MIF) drives inflammatory responses in the corneal epithelium by promoting caveolin-rich platform assembly in response to infection. J Biol Chem. 2013;288:8269–8278
44. Garrean S, Gao XP, Brovkovych V, et al. Caveolin-1 regulates NF-kappaB activation and lung inflammatory response to sepsis induced by lipopolysaccharide. J Immunol. 2006;177: 4853–4860
45. Feng H, Guo L, Song Z, et al. Caveolin-1 protects against sepsis by modulating inflammatory response, alleviating bacterial burden, and suppressing thymocyte apoptosis. J Biol Chem. 2010;285:25154–25160
46. Zhang PX, Murray TS, Villella VR, et al. Reduced caveolin-1 promotes hyperinflammation due to abnormal heme oxygenase- 1 localization in lipopolysaccharide-challenged macrophages with dysfunctional cystic fibrosis transmembrane conductance regulator. J Immunol. 2013;190:5196–5206
47. Gadjeva M, Paradis-Bleau C, Priebe GP, Fichorova R, Pier GB. Caveolin-1 modifies the immunity to Pseudomonas aeruginosa. J Immunol. 2010;184:296–302
48. Wang XM, Kim HP, Song R, Choi AM. Caveolin-1 confers antiinflammatory effects in murine macrophages via the MKK3/p38 MAPK pathway. Am J Respir Cell Mol Biol. 2006; 34:434–442
49. Medina FA, de Almeida CJ, Dew E, et al. Caveolin-1-deficient mice show defects in innate immunity and inflammatory immune response during Salmonella enterica serovar Typhimurium infection. Infect Immun. 2006;74:6665–6674
50. Wang XM, Kim HP, Nakahira K, Ryter SW, Choi AM. The heme oxygenase-1/carbon monoxide pathway suppresses TLR4 signaling by regulating the interaction of TLR4 with caveolin- 1. J Immunol. 2009;182:3809–3818
51. Rosenbaum JT, Woods A, Kezic J, Planck SR, Rosenzweig HL. Contrasting ocular effects of local versus systemic endotoxin. Invest Ophthalmol Vis Sci. 2011;52:6472–6477
52. Ramadan RT, Ramirez R, Novosad BD, Callegan MC. Acute inflammation and loss of retinal architecture and function during experimental Bacillus endophthalmitis. Curr Eye Res. 2006;31:955–965
53. Conrady CD, Zheng M, van Rooijen N, et al. Microglia and a functional type I IFN pathway are required to counter HSV-1- driven brain lateral ventricle enlargement and encephalitis. J Immunol. 2013;190:2807–2817
54. Ishida S, Usui T, Yamashiro K, et al. VEGF164 is proinflammatory in the diabetic retina. Invest Ophthalmol Vis Sci. 2003;44: 2155–2162
55. Wuest TR, Carr DJ. Dysregulation of CXCR3 signaling due to CXCL10 deficiency impairs the antiviral response to herpes simplex virus 1 infection. J Immunol. 2008;181:7985–7993
56. Joussen AM, Murata T, Tsujikawa A, Kirchhof B, Bursell SE, Adamis AP. Leukocyte-mediated endothelial cell injury and death in the diabetic retina. Am J Pathol. 2001;158:147–152
57. Kezic J, Taylor S, Gupta S, Planck SR, Rosenzweig HL, Rosenbaum JT. Endotoxin-induced uveitis is primarily dependent on radiation-resistant cells and on MyD88 but not TRIF. J Leukoc Biol. 2011;90:305–311
58. Rosenzweig HL, Woods A, Clowers JS, Planck SR, Rosenbaum JT. The NLRP3 inflammasome is active but not essential in endotoxin-induced uveitis. Inflamm Res. 2012;61:225–231
59. Trichonas G, Manola A, Morizane Y, et al. A novel nonradioactive method to evaluate vascular barrier breakdown and leakage. Invest Ophthalmol Vis Sci. 2010;51:1677–1682
60. Stamatovic SM, Keep RF, Wang MM, Jankovic I, Andjelkovic AV. Caveolae-mediated internalization of occludin and claudin-5 during CCL2-induced tight junction remodeling in brain endothelial cells. J Biol Chem. 2009;284:19053–19066
61. Fu Y, Moore XL, Lee MK, et al. Caveolin-1 plays a critical role in the differentiation of monocytes into macrophages. Arterioscler Thromb Vasc Biol. 2012;32:e117–e125
62. Loomis SJ, Kang JH, Weinreb RN, et al. Association of CAV1/ CAV2 genomic variants with primary open-angle glaucoma overall and by gender and pattern of visual field loss. Ophthalmology. 2014;121:508–516
63. Thorleifsson G, Walters GB, Hewitt AW, et al. Common variants near CAV1 and CAV2 are associated with primary open-angle glaucoma. Nat Genet. 2010;42:906–909
64. Wiggs JL, Kang JH, Yaspan BL, et al. Common variants near CAV1 and CAV2 are associated with primary open-angle glaucoma in Caucasians from the USA. Hum Mol Genet. 2011; 20:4707–4713.
65. Kang JH, Loomis SJ, Yaspan BL, et al. Vascular tone pathway polymorphisms in relation to primary open-angle glaucoma. Eye (Lond). 2014;28:662–671
66. Song L, Ge S, Pachter JS. Caveolin-1 regulates expression of junction-associated proteins in brain microvascular endothelial cells. Blood. 2007;109:1515–1523
67. Carman CV, Springer TA. A transmigratory cup in leukocyte diapedesis both through individual vascular endothelial cells and between them. J Cell Biol. 2004;167:377–388
68. Engel D, Beckers L, Wijnands E, et al. Caveolin-1 deficiency decreases atherosclerosis by hampering leukocyte influx into the arterial wall and generating a regulatory T-cell response. FASEB J. 2011;25:3838–3848
69. Marmon S, Hinchey J, Oh P, et al. Caveolin-1 expression determines the route of neutrophil extravasation through skin microvasculature. Am J Pathol. 2009;174:684–692
70. Omri S, Behar-Cohen F, de Kozak Y, et al. Microglia/ macrophages migrate through retinal epithelium barrier by a transcellular route in diabetic retinopathy: role of PKCzeta in the Goto Kakizaki rat model. Am J Pathol. 2011;179:942–953
71. Cai L, Yi F, Dai Z, et al. Loss of caveolin-1 and adiponectin induces severe inflammatory lung injury following LPS challenge through excessive oxidative/nitrative stress. Am J Physiol Lung Cell Mol Physiol. 2014;306:L566–L73
72. Hu G, Ye RD, Dinauer MC, Malik AB, Minshall RD. Neutrophil caveolin-1 expression contributes to mechanism of lung inflammation and injury. Am J Physiol Lung Cell Mol Physiol. 2008;294:L178–L186
73. Yousuf MA, Zhou X, Mukherjee S, et al. Caveolin-1 associated adenovirus entry into human corneal cells. PLoS One. 2013;8: e77462
74. Kumar A, Shamsuddin N. Retinal M¨uller glia initiate innate response to infectious stimuli via toll-like receptor signaling. PLoS One. 2012;7:e29830
75. Song L, Pachter JS. Monocyte chemoattractant protein-1 alters expression of tight junction-associated proteins in brain microvascular endothelial cells. Microvasc Res. 2004;67:78–89.